The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
mTOR Hyperactivation by Ablation of Tuberous Sclerosis Complex 2 in the Mouse Heart Induces Cardiac Dysfunction with the Increased Number of Small Mitochondria Mediated through the Down-Regulation of Autophagy
Open accessAbstract
Mammalian target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth, proliferation and metabolism. mTORC1 regulates protein synthesis positively and autophagy negatively. Autophagy is a major system to manage bulk degradation and recycling of cytoplasmic components and organelles. Tuberous sclerosis complex (TSC) 1 and 2 form a heterodimeric complex and inactivate Ras homolog enriched in brain, resulting in inhibition of mTORC1. Here, we investigated the effects of hyperactivation of mTORC1 on cardiac function and structure using cardiac-specific TSC2-deficient (TSC2-/-) mice. TSC2-/- mice were born normally at the expected Mendelian ratio. However, the median life span of TSC2-/- mice was approximately 10 months and significantly shorter than that of control mice. TSC2-/- mice showed cardiac dysfunction and cardiomyocyte hypertrophy without considerable fibrosis, cell infiltration or apoptotic cardiomyocyte death. Ultrastructural analysis of TSC2-/- hearts revealed misalignment, aggregation and a decrease in the size and an increase in the number of mitochondria, but the mitochondrial function was maintained. Autophagic flux was inhibited, while the phosphorylation level of S6 or eukaryotic initiation factor 4E -binding protein 1, downstream of mTORC1, was increased. The upregulation of autophagic flux by trehalose treatment attenuated the cardiac phenotypes such as cardiac dysfunction and structural abnormalities of mitochondria in TSC2-/- hearts. The results suggest that autophagy via the TSC2-mTORC1 signaling pathway plays an important role in maintenance of cardiac function and mitochondrial quantity and size in the heart and could be a therapeutic target to maintain mitochondrial homeostasis in failing hearts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“| Cardiomyopathies | Cardiomyocyte‐specific deletion of Tsc2 | Exacerbated cardiac hypertrophy and premature death after mTORC1 hyperactivation | Taneike et al (2016) |”
From Autophagy in major human diseases (2021) · cites this paper as Taneike et al (2016)
In the citing paper
“In this scenario, the persistent activation of MTORC1 lowers the capacity of cardiomyocytes to sustain pressure overload‐induced stress, as testified to by the fact that mice bearing knock‐in mutation in the MTORC1 inhibitor Tsc2 (TSC complex subunit 2) develop heart disease (Taneike et al, 2016), while succumbing to pressure overload (Ranek et al, 2019).”
From Autophagy in major human diseases (2021) · cites this paper as Taneike et al, 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 4×
“mTORC1 inhibits autophagy [4] by phosphorylating unc-51 like autophagy activating kinase 1 (ULK1), a mammalian ortholog of Atg1 [5].”
BackgroundInfluentialAutophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418 · cited 1×
“In autophagy, an isolation membrane sequesters a part of the cytoplasm or organelles including mitochondria to form an autophagosome [6].”
BackgroundGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Autophagy · doi:10.1080/15548627.2015.1100356 · Cited by 5,894
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 4,330 · cited 1×
“Since mTORC1 is known to be a negative regulator of autophagy in mammalian cells [4], we estimated the autophagic activity in TSC2 hearts (Fig 3C) [32].”
Mitochondrial Fission, Fusion, and Stress
Youle, R. J., & van der Bliek, A. M. (2012) · Science · doi:10.1126/science.1219855 · Cited by 3,674 · cited 1×
“mitochondria are determined by fusion and fission, followed by autophagy [46].”
BackgroundYoule, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273 · cited 1×
“PINK1 and Parkin are known to be key molecules for damaged mitochondria clearance via ubiquitination and mitophagy in neuron [50].”
BackgroundTSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083 · cited 1×
“Akt-mediated phosphorylation of TSC2 inhibits the function of the TSC1/2 complex [14], resulting in activation of mTORC1.”
BackgroundPhosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy
Egan, D. F., Shackelford, D. B., Mihaylova, M. M., Gelino, S., Kohnz, R. A., Mair, W., Vasquez, D. S., Joshi, A., Gwinn, D. M., Taylor, R., et al. (2011) · Science · doi:10.1126/science.1196371 · Cited by 2,600
Laplante, M., & Sabatini, D. M. (2009) · Journal of Cell Science · doi:10.1242/jcs.051011 · Cited by 2,170 · cited 3×
“mTORC1 positively regulates cell growth and proliferation by promoting biosynthesis of proteins and lipids and mitochondrial metabolism and biogenesis and also by limiting autophagy [1].”
BackgroundInfluentialRheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911 · cited 1×
“The TSC1/2 complex is a GTPase-activating protein that catalyses the conversion of Rheb-GTP to Rheb-GDP [11] and inactivates Rheb, resulting in inhibition of mTORC1 signaling [12, 13].”
BackgroundThoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803 · cited 2×
“mTORC1 inhibits autophagy [4] by phosphorylating unc-51 like autophagy activating kinase 1 (ULK1), a mammalian ortholog of Atg1 [5].”
BackgroundDuring autophagy mitochondria elongate, are spared from degradation and sustain cell viability
Gomes, L. C., Benedetto, G. D., & Scorrano, L. (2011) · Nature Cell Biology · doi:10.1038/ncb2220 · Cited by 1,735 · cited 1×
“When autophagy is induced in the cells by nutrient depletion, mitochondria elongate [8].”
BackgroundThe role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520 · cited 3×
“Our previous results showed that inhibition of autophagy in the heart by ablation of Atg5 induced misalignment and heterogeneous size of mitochondria and damage of intramitochondrial structure, impaired mitochondrial function and increased oxidative stress [7, 28].”
BackgroundSelf-citationmTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex
Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K., & Puigserver, P. (2007) · Nature · doi:10.1038/nature06322 · Cited by 1,488 · cited 2×
“mTOR controls mitochondrial oxidative function through a yin yang 1‒PGC-1alpha transcriptional complex [3].”
BackgroundRoczniak-Ferguson, A., Petit, C. S., Froehlich, F., Qian, S., Ky, J., Angarola, B., Walther, T. C., & Ferguson, S. M. (2012) · Science Signaling · doi:10.1126/scisignal.2002790 · Cited by 1,366 · cited 1×
“mTORC1 has been reported to regulate autophagy by signalling to ULK1 and lysosome homeostasis [5, 42].”
BackgroundThe TSC1–TSC2 complex: a molecular switchboard controlling cell growth
Huang, J., & Manning, B. D. (2008) · Biochemical Journal · doi:10.1042/bj20080281 · Cited by 1,237 · cited 1×
“hamartomas) in many organs, such as brain, kidneys, skin, heart and lungs [10].”
BackgroundRegulation of cap-dependent translation by eIF4E inhibitory proteins
Richter, J. D., & Sonenberg, N. (2005) · Nature · doi:10.1038/nature03205 · Cited by 970 · cited 1×
“The phosphorylation of 4E-BP1 prevents its binding to eIF4E, enabling eIF4E to promote cap-dependent translation [2].”
BackgroundMorita, M., Gravel, S.-P., Chénard, V., Sikström, K., Zheng, L., Alain, T., Gandin, V., Avizonis, D., Arguello, M., Zakaria, C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.001 · Cited by 842 · cited 3×
“This is in agreement with the previously reported in vitro studies that mitochondrial activity is stimulated and ATP levels are increased under the condition of constitutive mTORC1 activation in TSC2-deficient or knockdown cells [33, 43, 44].”
BackgroundResultTrounce, I. A., Kim, Y. L., Jun, A. S., & Wallace, D. C. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)64044-0 · Cited by 746 · cited 1×
“The activities of NADH cytochrome-c oxidoreductase (complex I + III) and succinate cytochrome-c oxidoreductase (complex II + III) were determined in mitochondrial fractions freshly isolated from hearts using previously described spectrophotometric methods [27].”
MethodmTOR Is Essential for Growth and Proliferation in Early Mouse Embryos and Embryonic Stem Cells
Murakami, M., Ichisaka, T., Maeda, M., Oshiro, N., Hara, K., Edenhofer, F., Kiyama, H., Yonezawa, K., & Yamanaka, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6710-6718.2004 · Cited by 624 · cited 1×
“In mice, the deficiency of mTORC1 leads to embryonic lethality [18, 19].”
BackgroundSchieke, S. M., Phillips, D., McCoy, J. P., Aponte, A. M., Shen, R.-F., Balaban, R. S., & Finkel, T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603536200 · Cited by 623 · cited 1×
“This is in agreement with the previously reported in vitro studies that mitochondrial activity is stimulated and ATP levels are increased under the condition of constitutive mTORC1 activation in TSC2-deficient or knockdown cells [33, 43, 44].”
ResultThe Drosophila Tuberous Sclerosis Complex Gene Homologs Restrict Cell Growth and Cell Proliferation
Tapon, N., Ito, N., Dickson, B. J., Treisman, J. E., & Hariharan, I. K. (2001) · Cell · doi:10.1016/s0092-8674(01)00332-4 · Cited by 542 · cited 1×
“Studies using Drosophila revealed that loss-of-function mutations of TSC1, TSC2 and both genes combined lead to organ overgrowth via increased cell proliferation and cell-autonomous increase in size [16, 17].”
MethodLoss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
Zhang, H., Cicchetti, G., Onda, H., Koon, H. B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, C. L., & Kwiatkowski, D. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17222 · Cited by 538 · cited 1×
“The phosphorylation level of Akt was significantly decreased in TSC2 hearts compared with TSC2 hearts, which is consistent with the existence of a negative feedback loop [31].”
BackgroundPotter, C. J., Huang, H., & Xu, T. (2001) · Cell · doi:10.1016/s0092-8674(01)00333-6 · Cited by 521
Gangloff, Y.-G., Mueller, M., Dann, S. G., Svoboda, P., Sticker, M., Spetz, J.-F., Um, S. H., Brown, E. J., Cereghini, S., Thomas, G., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9508-9516.2004 · Cited by 485 · cited 1×
“In mice, the deficiency of mTORC1 leads to embryonic lethality [18, 19].”
BackgroundLoss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
Zhang, H., Cicchetti, G., Onda, H., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317222 · Cited by 482
Manning, B. D. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200408161 · Cited by 476
Inhibition of autophagy in the heart induces age-related cardiomyopathy
Taneike, M., Yamaguchi, O., Nakai, A., Hikoso, S., Takeda, T., Mizote, I., Oka, T., Tamai, T., Oyabu, J., Murakawa, T., et al. (2010) · Autophagy · doi:10.4161/auto.6.5.11947 · Cited by 450
Self-citationOnda, H., Lueck, A., Marks, P. W., Warren, H. B., & Kwiatkowski, D. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7319 · Cited by 349 · cited 1×
“Since conventional TSC2-deficient mice are embryonic lethal [23, 24], we used cardiac-specific TSC2-deficient mice to examine the effect of mTORC1 hyperactivation on protein degradation and mitochondrial dynamics as well as protein synthesis in cardiomyocytes in this study.”
MethodStimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy
Schaeffer, V., Lavenir, I., Ozcelik, S., Tolnay, M., Winkler, D. T., & Goedert, M. (2012) · Brain · doi:10.1093/brain/aws143 · Cited by 343
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice
Zhang, D., Contu, R., Latronico, M. V. G., Zhang, J. L., Rizzi, R., Catalucci, D., Miyamoto, S., Huang, K., Ceci, M., Gu, Y., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43008 · Cited by 337 · cited 1×
“caused by enhanced dephosphorylation of 4E-BP1 [21].”
Mitochondrial Structure and Function Are Disrupted by Standard Isolation Methods
Picard, M., Taivassalo, T., Ritchie, D., Wright, K. J., Thomas, M. M., Romestaing, C., & Hepple, R. T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018317 · Cited by 318 · cited 1×
“It has been reported that isolation of mitochondria causes the difference in functional characteristics compared to intact mitochondria in permeabilized miofibers [45].”
BackgroundRodríguez-Navarro, J. A., Rodríguez, L., Casarejos, M. J., Solano, R. M., Gómez, A., Perucho, J., Cuervo, A. M., García de Yébenes, J., & Mena, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.014 · Cited by 298 · cited 1×
“Recently, it is reported that trehalose acts as an mTOR-independent autophagy activator and can reduce protein aggregates in some mouse disease models [35–37].”
Backgroundrheb, a growth factor- and synaptic activity-regulated gene, encodes a novel Ras-related protein.
Yamagata, K., Sanders, L. K., Kaufmann, W. E., Yee, W., Barnes, C. A., Nathans, D., & Worley, P. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34012-7 · Cited by 296
Kobayashi, T., Minowa, O., Kuno, J., Mitani, H., Hino, O., & Noda, T. (1999) · PubMed · Cited by 274
Role of trehalose phosphate synthase and trehalose during hypoxia: from flies to mammals
Chen, Q., & Haddad, G. G. (2004) · Journal of Experimental Biology · doi:10.1242/jeb.01133 · Cited by 257 · cited 2×
“Trehalose is a non-reducing disaccharide found in a wide variety of organisms, including bacteria, yeast, invertebrates, and plants and functions to protect cells against various environmental stresses [34].”
BackgroundBenvenuto, G., Li, S., Brown, S. J., Braverman, R., Vass, W. C., Cheadle, J. P., Halley, D. J., Sampson, J. R., Wienecke, R., & DeClue, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1204009 · Cited by 252 · cited 2×
“TSC1 and TSC2 associate with each other to form a heterodimer [29, 30].”
BackgroundTSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase
Chong-Kopera, H., Inoki, K., Li, Y., Zhu, T., Garcia-Gonzalo, F. R., Rosa, J. L., & Guan, K.-L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500451200 · Cited by 234 · cited 2×
“TSC1 and TSC2 associate with each other to form a heterodimer [29, 30].”
BackgroundRapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex
Sato, A., Kasai, S., Kobayashi, T., Takamatsu, Y., Hino, O., Ikeda, K., & Mizuguchi, M. (2012) · Nature Communications · doi:10.1038/ncomms2295 · Cited by 220 · cited 1×
“It is reported that mTORC1 inhibitors such as rapamycin can be pharmacological treatments of TSC disease [54, 55].”
BackgroundDavies, J. E., Sarkar, S., & Rubinsztein, D. C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi422 · Cited by 207 · cited 1×
“Recently, it is reported that trehalose acts as an mTOR-independent autophagy activator and can reduce protein aggregates in some mouse disease models [35–37].”
BackgroundCardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis
Yamaguchi, O., Watanabe, T., Nishida, K., Kashiwase, K., Higuchi, Y., Takeda, T., Hikoso, S., Hirotani, S., Asahi, M., Taniike, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420317 · Cited by 204 · cited 1×
“Mice bearing the TSC2 allele were crossed with transgenic mice expressing Cre recombinase under the control of alpha-myosin heavy chain promoter (alpha-MyHC-Cre) [26].”
MethodSelf-citationEffects of Rapamycin in the Eker Rat Model of Tuberous Sclerosis Complex
Kenerson, H., Dundon, T. A., & Yeung, R. S. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000147727.78571.07 · Cited by 162 · cited 1×
“It is reported that mTORC1 inhibitors such as rapamycin can be pharmacological treatments of TSC disease [54, 55].”
BackgroundDutta, A. K., Sabirov, R. Z., Uramoto, H., & Okada, Y. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.069245 · Cited by 139 · cited 1×
“ATP is released from cardiomyocytes [39, 40] and immediately metabolized to adenosine by ATPases that have their catalytic domain on the outer side of plasma membrane.”
BackgroundNeuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1
Nardo, A. D., Wertz, M. H., Kwiatkowski, E. R., Tsai, P. T., Leech, J. D., Greene-Colozzi, E. A., Goto, J., Dilsiz, P., Talos, D. M., Clish, C. B., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu101 · Cited by 123 · cited 2×
“AMPK activates autophagy not only by inhibition of mTORC1 but also by direct phosphorylation of ULK1, which is required for autophagy induction [5, 48, 49].”
BackgroundAnalysis of mTOR signaling by the small G‐proteins, Rheb and RhebL1
Tee, A. R., Blenis, J., & Proud, C. G. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.07.054 · Cited by 111 · cited 1×
“The TSC1/2 complex is a GTPase-activating protein that catalyses the conversion of Rheb-GTP to Rheb-GDP [11] and inactivates Rheb, resulting in inhibition of mTORC1 signaling [12, 13].”
BackgroundTabancay, A. P., Gau, C., Machado, I. M. P., Uhlmann, E. J., Gutmann, D. H., Guo, L., & Tamanoi, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306553200 · Cited by 110 · cited 1×
“The TSC1/2 complex is a GTPase-activating protein that catalyses the conversion of Rheb-GTP to Rheb-GDP [11] and inactivates Rheb, resulting in inhibition of mTORC1 signaling [12, 13].”
BackgroundZhu, Y., Pires, K. M. P., Whitehead, K. J., Olsen, C. D., Wayment, B. E., Zhang, Y. C., Bugger, H., Ilkun, O. L., Litwin, S. E., Thomas, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054221 · Cited by 106 · cited 1×
“Cardiac-specific mTOR-deficient mice are also embryonic lethal [20].”
BackgroundGeneration of a conditional disruption of the Tsc2 gene
Hernandez, O., Way, S. W., McKenna, J. T., & Gambello, M. J. (2007) · genesis · doi:10.1002/dvg.20271 · Cited by 98
Self-citationA mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes
Meikle, L. M., McMullen, J. R., Sherwood, M. C., Lader, A. S., Walker, V., Chan, J. A.-W., & Kwiatkowski, D. J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddi039 · Cited by 77 · cited 2×
“Although the molecular mechanisms underlying the development of dilated cardiomyopathy in the TSC1-deficient mice have not been investigated, histological analysis of the mice showed the occurrence of scattered foci of enlarged cardiomyocytes accumulating glycogen without any evidence of proliferation in the lesion [3…”
BackgroundMolecular cloning, sequencing and expression of cDNA encoding human trehalase
Ishihara, R., Taketani, S., Sasai‐Takedatsu, M., Kino, M., Tokunaga, R., & Kobayashi, Y. (1997) · Gene · doi:10.1016/s0378-1119(97)00455-1 · Cited by 72
Koyanagi, M., Asahara, S., Matsuda, T., Hashimoto, N., Shigeyama, Y., Shibutani, Y., Kanno, A., Fuchita, M., Mikami, T., Hosooka, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023238 · Cited by 72 · cited 2×
“This is in agreement with the previously reported in vitro studies that mitochondrial activity is stimulated and ATP levels are increased under the condition of constitutive mTORC1 activation in TSC2-deficient or knockdown cells [33, 43, 44].”
ResultFroldi, G., & Belardinelli, L. (1990) · Circulation Research · doi:10.1161/01.res.67.4.960 · Cited by 53 · cited 1×
“Since adenosine is known to have a negative effect on heart rate [41], increased cytosolic ATP level may result in a decrease in heart rate in TSC2 mice.”
BackgroundLacher, M. D., Pincheira, R., Zhu, Z., Camoretti-Mercado, B., Matli, M. R., Warren, R. S., & Castro, A. F. (2010) · Oncogene · doi:10.1038/onc.2010.393 · Cited by 48 · cited 1×
“AMPK phosphorylation was impaired in our TSC2 hearts, conversely the level was reported to be increased in tumor-derived cells or neurons lacking TSC2 [47, 48].”
BackgroundTamai, T., Yamaguchi, O., Hikoso, S., Takeda, T., Taneike, M., Oka, T., Oyabu, J., Murakawa, T., Nakayama, H., Uno, Y., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423640 · Cited by 48 · cited 1×
“We previously investigated the role of mTORC1 in the heart using cardiac-specific Rheb-deficient mice, where mTORC1 was downregulated [22].”
BackgroundSelf-citationJoubert, F., Wilding, J. R., Fortin, D., Domergue, V., Novotová, M., Ventura‐Clapier, R., & Veksler, V. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.157677 · Cited by 43 · cited 1×
“Cytoarchitectural disorganization would lead to cardiac dysfunction [53].”
BackgroundRestriction of trophic factors and nutrients induces PARKIN expression
Klinkenberg, M., Gispert, S., Dominguez-Bautista, J. A., Braun, I., Auburger, G., & Jendrach, M. (2012) · neurogenetics · doi:10.1007/s10048-011-0303-8 · Cited by 42 · cited 7×
“Further study is requested to clarify the effect of the decreases in PINK1/Parkin levels on the cardiac phenotype and mitochondrial morphology observed in TSC2-/- mice.”
BackgroundInfluentialKunugi, S., Iwabuchi, S., Matsuyama, D., Okajima, T., & Kawahara, K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.068 · Cited by 17 · cited 1×
“ATP is released from cardiomyocytes [39, 40] and immediately metabolized to adenosine by ATPases that have their catalytic domain on the outer side of plasma membrane.”
Background
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
New Insights Into the Role of mTOR Signaling in the Cardiovascular System
Sciarretta, S., Forte, M., Frati, G., & Sadoshima, J. (2018) · Circulation Research · doi:10.1161/circresaha.117.311147 · Cited by 491
“sociated with an impairment of autophagic flux, which were reversed by pharmacological autophagy reactivation.(127)”
Inflammation and metabolic cardiomyopathy
Nishida, K., & Otsu, K. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx012 · Cited by 329
“trehalose treatment attenuated cardiac dysfunction and structural abnormalities of mitochondria in the TSC2-deficient mouse hearts.(107) The”
BackgroundSelf-citationAutophagy in Cardiovascular Aging
Abdellatif, M., Sedej, S., Carmona-Gutierrez, D., Madeo, F., & Kroemer, G. (2018) · Circulation Research · doi:10.1161/circresaha.118.312208 · Cited by 239
“Reactivation of autophagy by trehalose treatment attenuated cardiac dysfunction and structural abnormalities of mitochondria in tuberous sclerosis complex 2-deficient hearts.(166) These results suggest that autophagy via the tuberous sclerosis complex 2-mTORC1 signaling pathway”
BackgroundMechanisms contributing to cardiac remodelling
Wu, Q.-Q., Xiao, Y., Yuan, Y., Ma, Z.-G., Liao, H.-H., Liu, C., Zhu, J.-X., Yang, Z., Deng, W., & Tang, Q.-Z. (2017) · Clinical Science · doi:10.1042/cs20171167 · Cited by 210
Metadata
- Authors
- Taneike, M., Nishida, K., Omiya, S., Zarrinpashneh, E., Misaka, T., Kitazume-Taneike, R., Austin, R., Takaoka, M., Yamaguchi, O., Gambello, M. J., Shah, A. M., & Otsu, K.
- Affiliations
- King's College London (GB)
- The University of Osaka (JP)
- Emory University (US)
- Corresponding author
- Otsu, Kinya
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-03-29
- Volume
- 11
- Issue
- 3
- Pages
- e0152628
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4811538
- OpenAlex
- W2324750755
- Cited by
- 57
- References
- 57
- Citations by year
- 2025: 7 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 10 · 2016: 2
- FWCI
- 7.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- British Heart Foundation (CH/11/3/29051, RG/11/12/29052, CH/11/3/29051, RG/11/12/29052)
- King's College London
- Medical Research Council (MR/K019031/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- tuberous sclerosis complex 2, mTORC1 hyperactivation, cardiac dysfunction, autophagy, mitochondrial homeostasis, cardiomyocyte hypertrophy, trehalose, S6 phosphorylation, eIF4E-binding protein 1, heart mitochondria, heart failure
- MeSH terms
- Mechanistic Target of Rapamycin Complex 1, Tuberous Sclerosis Complex 2 Protein, Animals, Autophagy, Enzyme Activation, Heart, Cardiomegaly, Mice, Inbred C57BL, Mitochondria, Heart, Organ Specificity, Phenotype, Protein Biosynthesis, Trehalose, Signal Transduction, Down-Regulation, Up-Regulation, Tumor Suppressor Proteins, Multiprotein Complexes, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.